Viva Biotech Showcases Integrated PK/PD Platform Across Small Molecules, Peptides, PROTACs, and Antibodies

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and m...

December 30, 2025 | Tuesday | News
T-MAXIMUM Pharmaceutical Secures FDA IND Clearance for Allogeneic CAR-T MT027 in Recurrent Glioblastoma

T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food an...

December 29, 2025 | Monday | News
Foresee Pharmaceuticals’ FP-001 Meets Phase 3 Primary Endpoint in Central Precocious Puberty

The proportion of patients with serum luteinizing hormone (LH) suppression to < 4 mIU/mL at 60 minutes following a GnRHa stimula...

December 29, 2025 | Monday | News
ABL Bio Secures $55M from Eli Lilly to Accelerate Grabody Platform Expansion

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D o...

December 29, 2025 | Monday | News
Mabwell Secures FDA IND Clearance for Anti-ST2 Antibody 9MW1911 in Moderate-to-Severe COPD

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance fr...

December 26, 2025 | Friday | News
Caliway Submits FDA IND for Phase 2 Study of CBL-514 in Combination With Eli Lilly’s Zepbound® for Weight Management

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical...

December 26, 2025 | Friday | News
Innovent’s TABOSUN® Plus TYVYT® Becomes World’s First Approved Dual-IO Neoadjuvant Therapy for MSI-H/dMMR Colon Cancer in China

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant...

December 26, 2025 | Friday | News
SN Bioscience’s SNB-101 Secures FDA Orphan Drug Designation for Gastric Cancer

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gast...

December 25, 2025 | Thursday | News
Kashiv BioSciences Secures ~$78 Million to Expand Biologics Manufacturing Capacity in India

The INR 648 crore facility will drive investment in state-of-the-art biologics manufacturing facility in Pipan, Gujarat The facility will enhance te...

December 24, 2025 | Wednesday | News
Samsung Biologics Enters U.S. Manufacturing with $280M Rockville Site Acquisition from GSK

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional inv...

December 23, 2025 | Tuesday | News
Takeda’s Zasocitinib Delivers Strong Phase 3 Wins in Plaque Psoriasis

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psor...

December 19, 2025 | Friday | News
Orum Therapeutics Raises ₩145 Billion (US$100M) to Advance Next-Generation Degrader-Antibody Conjugates

Funding supports advancing therapeutic programs toward clinical development, expanding discovery across novel payload classes to accelerate next-gene...

December 19, 2025 | Friday | News
Harbour BioMed And Bristol Myers Squibb Forge Global Multi-Specific Antibody Alliance

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immuno...

December 18, 2025 | Thursday | News
Antengene Expands XPOVIO® Approval in Malaysia to Relapsed or Refractory DLBCL

Antengene Corporation Limited, a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing fir...

December 18, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close